Green nanotechnology from cumin phytochemicals: Generation of biocompatible gold nanoparticles

International Journal of Green Nanotechnology: Biomedicine

Volumn 1, Issue 1, 2009, Pages

  Katti, Kavita ^a   Chanda, Nripen ^a   Shukla, Ravi ^a   Zambre, Ajit ^a   Suibramanian, Thilakavathi ^a   Kulkarni, Rajesh R ^a   Kannan, Raghuraman ^a,b   Katti, Kattesh V ^a,b  

^a UNIVERSITY OF MISSOURI   (United States)

^b Greennano Company   (United States)

Author keywords

Biocompatible gold nanoparticles; Cell internalization; Cumin; Green nanotechnology; MTT assays; Prostate tumor; Sodium tetrachloro aurate

Indexed keywords

EID: 77649117182     PISSN: 1943085X     EISSN: 19430906     Source Type: Journal    
DOI: 10.1080/19430850902931599     Document Type: Article

References (67)

1. Azzazy, H. M.; Mansour, M. M.; Kazmierczak, S. C. Nanodiagnostics: A new frontier for clinical laboratory medicine. Clin. Chem. 2006, 52, 1238-1246.
2. Bhattacharya, R.; Mukherjee, P. Biological properties of "naked" metal nanoparticles. Adv. Drug. Deliv. Rev. 2008, 60, 1289-1306.
3. Han, G.; Ghosh, P.; Rotello, V. M. Multi-functional gold nanoparticles for drug delivery. Adv. Exp. Med. Biol. 2007, 620, 48-56.
4. Han, G.; Ghosh, P.; Rotello, V. M. Functionalized gold nanoparticles for drug delivery. Nanomedicine 2007, 2, 113-123.
5. Jain, K. K. Role of nanobiotechnology in developing personalized medicine for cancer. Technol. Cancer Res. Treat. 2005, 4, 645-650.
6. Jain, K. K. Nanotechnology in clinical laboratory diagnostics. Clin. Chim. Acta 2005, 358, 37-54.
7. Jain, K. K. Applications of nanobiotechnology in clinical diagnostics. Clin. Chem. 2007, 53, 2002-2009.
8. Longmire, M.; Choyke, P. L.; Kobayashi, H. Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats. Nanomedicine 2008, 3, 703-17.
9. Sonvico, F.; Dubernet, C.; Colombo, P.; Couvreur, P. Metallic colloid nanotechnology, applications in diagnosis and therapeutics. Curr. Pharm. Des. 2005, 11, 2095-2105.
10. Sperling, R. A.; Rivera Gil, P.; Zhang, F.; Zanella, M.; Parak, W. J. Biological applications of gold nanoparticles. Chem. Soc. Rev. 2008, 37, 1896-1908.
11. Yang, D. P.; Cui, D. X. Advances and prospects of gold nanorods. Chem. Asian J. 2008, 3, 2010-2022.
12. Walsh, D.; Arcelli, L.; Ikoma, T.; Tanaka, J.; Mann, S. Dextran templating for the synthesis of metallic and metal oxide sponges. Nat. Mater. 2003, 2, 386-390.
13. Yang, M. D.; Liu, Y. K.; Shen, J. L.; Wu, C. H.; Lin, C. A.; Chang, W. H.; Wang, H. H.; Yeh, H. I.; Chan, W. H.; Parak, W. J. Improvement of conversion efficiency for multi-junction solar cells by incorporation of Au nanoclusters. Opt. Express 2008, 16, 15754-15758.
14. Kim, W. B.; Voitl, T.; Rodriguez-Rivera, G. J.; Dumesic, J. A. Powering fuel cells with CO via aqueous polyoxometalates and gold catalysts. Science 2004, 305, 1280-1283.
15. Esumi, K.; Kameo, A.; Suzuki, A.; Torigoe, K. Preparation of gold nanoparticles in formamide and N, Ndimethylformamide in the presence of poly(amidoamine) dendrimers with surface methyl ester groups. Colloids Surfaces A Physicochem. Eng. Aspects 2001, 189, 155-161.
16. Feitz, A.; Guan, J.; Waite, D. Process for producing a nanoscale zero-valent metal. United States Patent Application US 2006/0083924, April 20, 2006.
17. Lin, J.; Zhou, W.; O'Connor, C. J. Formation of ordered arrays of gold nanoparticles from CTAB reverse micelles. Mater. Lett. 2001, 49, 282-286.
18. Deorukhkar, A.; Krishnan, S.; Sethi, G.; Aggarwal, B. B. Back to basics: How natural products can provide the basis for new therapeutics. Expert Opin. Invest. Drugs 2007, 16, 1753-1773.
19. Nishino, H.; Satomi, Y.; Tokuda, H.; Masuda, M. Cancer control by phytochemicals. Curr. Pharmaceut. Design 2007, 13, 3394-3399.
20. Johnson, I.T. Phytochemicals and cancer. Proc. Nutr. Soc. 2007, 66, 207-215.
21. Kwon, K. H.; Barve, A.; Yu, S.; Huang, M. T.; Kong, A. N. Cancer chemoprevention by phytochemicals: Potential molecular targets, biomarkers and animal models. Acta Pharmacol. Sin. 2007, 28, 1409-1421.
22. Kaur, M.; Agarwal, R. Transcription factors:Molecular targets for prostate cancer intervention by phytochemicals Curr. Cancer Drug Targets 2007, 7, 355-367.
23. Dekker, M.; Verkerk, R. Dealing with variability in food production chains: a tool to enhance the sensitivity of epidemiological studies on phytochemicals. Eur. J. Nutr. 2003 42, 67-72.
24. Holst, B.;Williamson, G. Nutrients and phytochemicals: From bioavailability to bioefficacy beyond antioxidants. Curr. Opin. Biotechnol. 2008, 19, 73-82.
25. Record, I. R.; McInerney, J. K.; Dreosti, I. E. Black tea, green tea, and tea polyphenols. Effects on trace element status in weanling rats. Biol. Trace Elem. Res. 1996, 53, 27-43.
26. R̈ufer, C. E.; Kulling, S. E. Antioxidant activity of isoflavones and their major metabolites using different in vitro assays. J. Agric. Food Chem. 2006, 54, 2926-2931.
27. Siddiqui, I. A.; Adhami, V. M.; Bharali, D. J.; Hafeez, B. B.; Asim, M.; Khwaja, S. I.; Ahmad, N.; Cui, H.; Mousa, S. A.; Mukhtar, H. Introducing nanochemoprevention as a novel approach for cancer control: Proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res. 2009, 69, 1712-1716.
28. Albrecht, M. A.; Evans, C. W.; Raston, C. L. Green chemistry and the health implications of nanoparticles. Green Chem. 2006, 8, 417-432.
29. Roy, K.; Lahiri, S. A green method for synthesis of radioactive gold nanoparticles. Green Chem. 2006, 8, 1063-1066.
30. Hutchison, J. E. Greener nanoscience: a proactive approach to advancing applications and reducing implications of nanotechnology. ACS Nano. 2008, 2, 395-402.
31. Sharma, V.K.; Yngard, R.A.; Lin, Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci. 2009, 145, 83-96.
32. Vigneshwaran, N.; Nachane, R. P.; Balasubramanya, R. H.; Varadarajan, P. V. A novel one-pot 'green' synthesis of stable silver nanoparticles using soluble starch. Carbohydr. Res. 2006, 341, 2012-2018.
33. Shukla, R.; Nune, S. K.; Chanda, N.; Katti, K.; Mekapothula, S.; Kulkarni, R. R.; Welshons, W. V.; Kannan, R.;Katti, K.V. Soybeans as a phytochemical reservoir for the production and stabilization of biocompatible gold nanoparticles. Small 2008, 4, 1425-1436.
34. Nune, S. K. C., N.; Shukla, R.; Katti, K.; Kulkarni, R.R.; Subramanian T.; Mekapothula, S.; Kannan, R.; Katti, K. V. Green nanotechnology from tea: phytochemicals in tea as building blocks for production of biocompatible gold nanoparticles. J. Mater. Chem. 2009, 19, 2912-2920.
35. Ishikawa, T.; Takayanagi, T.; Kitajima, J. Watersoluble constituents of cumin: monoterpenoid glucosides. Chem Pharm Bull (Tokyo) 2002, 50, 1471-1478.
36. Behera, S.; Nagrajan, S.; Jagan Mohan Rao, L. Microwave heating and conventional roasting of cumin seeds (Cuminum cyminum L.) and effect on chemical composition of volatiles. Food Chem. 2004, 87, 25-29.
37. Alhaz, N.; Shamsudin, M. N.; Zamri, H. F.; Abdullah, R. Extraction of essential oil from Nigella sativa using supercritical carbon dioxide: Study of antibacterial activity. Am. J. Pharmacol. Toxicol. 2008, 3, 225-228.
38. Parlatan, A.; Saricoban, C.; Ozcan, M. M. Chemical composition and antimicrobial activity of the extracts of Kefe cumin (Laser trilobum L.) fruits from different regions. Int. J. Food Sci. Nutr. 2008, 1-12.
39. Khan, M. A. Chemical composition and medicinal properties of Nigella sativa Linn. Inflammopharmacology 1999, 7, 15-35.
40. Ramadan, M. F.; Morsel, J. T. Characterization of phospholipid composition of black cumin (Nigella sativa L.) seed oil. Nahrung 2002, 46, 240-4.
41. al-Gaby, A. M. Amino acid composition and biological effects of supplementing broad bean and corn proteins with Nigella sativa (black cumin) cake protein. Nahrung 1998, 42, 290-294.
42. Farag, S. E.; Abo-Zeid, M. Degradation of the natural mutagenic compound safrole in spices by cooking and irradiation. Nahrung 1997, 41, 359-361.
43. Aruna, K.; Sivaramakrishnan, V. M. Anticarcinogenic effects of some Indian plant products. Food Chem Toxicol. 1992, 30, 953-956.
44. Salim, E. I.; Fukushima, S. Chemopreventive potential of volatile oil from black cumin (Nigella sativa L.) seeds against rat colon carcinogenesis. Nutr. Cancer 2003, 45, 195-202.
45. Hanafy, M. S.; Hatem, M. E. Studies on the antimicrobial activity of Nigella sativa seed (black cumin). J. Ethnopharmacol. 1991, 34, 275-278.
46. Poliakoff, M.; Fitzpatrick, J. M.; Farren, T. R.; Anastas, P. T. Green chemistry: science and politics of change. Science 2002, 297, 807-810.
47. Poliakoff, M.; Licence, P. Sustainable technology: Green chemistry. Nature 2007, 450, 810-2.
48. Tang, S. L. Y.; Smith, R. L.; Poliakoff, M. Principles of green chemistry: Productively. Green Chem. 2005, 7, 761-762.
49. Shankar, S. S.; Rai, A.; Ankamwar, B.; Singh, A.; Ahmad, A.; Sastry, M. Biological synthesis of triangular gold nanoprisms. Nat. Mater. 2004, 3, 482-488.
50. Mohanpuria, P.; Rana, N. K.; Yadav, S. K. Biosynthesis of nanoparticles: technological concepts and future applications. J. Nanoparticle Res. 2007, 10, 507-517.
51. Daniel, M. C.; Astruc, D. Gold nanoparticles: Assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 2004, 104, 293-346.
52. Brust, M. W., M.; Bethell, D.; Schiffrin, D. J.; Whyman, R. Synthesis of thiol-derivatised gold nanoparticles in a two-phase liquid-liquid system. J. Chem. Soc. Chem. Commun. 1994, 801-802.
53. Abad, J. M.; Mertens, S. F.; Pita, M.; Fernandez, V. M.; Schiffrin, D. J. Functionalization of thioctic acidcapped gold nanoparticles for specific immobilization of histidine-tagged proteins. J. Am. Chem. Soc. 2005, 127, 5689-5694.
54. Roux, S.; Garcia, B.; Bridot, J. L.; Salome, M.; Marquette, C.; Lemelle, L.; Gillet, P.; Blum, L.; Perriat, P.; Tillement, O. Synthesis, characterization of dihydrolipoic acid capped gold nanoparticles, and functionalization by the electroluminescent luminol. Langmuir 2005, 21, 2526-2536.
55. Paciotti, G. F.; Myer, L.; Weinreich, D.; Goia, D.; Pavel, N.;McLaughlin, R. E.; Tamarkin, L. Colloidal gold: A novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004, 11, 169-183.
56. Kattumuri, V.; Katti, K.; Bhaskaran, S.; Boote, E. J.; Casteel, S. W.; Fent, G. M.; Robertson, D. J.; Chandrasekhar, M.;Kannan, R.; Katti, K.V. Gumarabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and x-ray-contrast-imaging studies. Small 2007, 3, 333-341.
57. Shaw, I. C. Gold-based therapeutic agents. Chem. Rev. 1999, 99, 2589-2600.
58. Chithrani, B. D.; Chan, W. C. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7, 1542-1550.
59. Hong, R.; Han, G.; Fernandez, J. M.; Kim, B. J.; Forbes, N. S.; Rotello, V. M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J. Am. Chem. Soc. 2006, 128, 1078-1079.
60. Nakai, T.; Kanamori, T.; Sando, S.; Aoyama, Y. Remarkably size-regulated cell invasion by artificial viruses. Saccharide-dependent self-aggregation of glycoviruses and its consequences in glycoviral gene delivery. J. Am. Chem. Soc. 2003, 125, 8465-8475.
61. Osaki, F.; Kanamori, T.; Sando, S.; Sera, T.;Aoyama, Y. A quantum dot conjugated sugar ball and its cellular uptake. On the size effects of endocytosis in the subviral region. J. Am. Chem. Soc. 2004, 126, 6520-6521.
62. Rensen, P.C.; Sliedregt, L. A.; Ferns, M.; Kieviet, E.; van Rossenberg, S. M.; van Leeuwen, S. H.; van Berkel, T. J.; Biessen, E. A. Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo. J. Biol. Chem. 2001, 276, 37577-37584.
63. Yang, P. H.; Sun, X.; Chiu, J. F.; Sun, H.; He, Q. Y. Transferrin-mediated gold nanoparticle cellular uptake. Bioconjug. Chem. 2005, 16, 494-496.
64. Na, H. K.; Surh, Y. J. Intracellular signaling network as a prime chemopreventive target of (-)-epigallocatechin gallate. Mol. Nutr. Food Res. 2006, 50, 152-159.
65. Sun de, J.; Liu, Y.; Lu, D. C.; Kim, W.; Lee, J. H.; Maynard, J.; Deisseroth, A. Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells. Hum. Pathol. 2007, 38, 1047-1056.
66. Benhar, M.; Dalyot, I.; Engelberg, D.; Levitzki, A. Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress. Mol. Cell. Biol. 2001, 21, 6913-6926.
67. Liebman, M. A.; Williams, B. R.; Daley, K. M.; Sharon, J. Generation and preliminary characterization of an antibody library with preferential reactivity to human colorectal cancer cells as compared to normal human blood cells. Immunol. Lett. 2004, 91, 179-188.